EXENT

Serial Number 79298814
Registration 6661783
700

Registration Progress

Application Filed
Feb 17, 2020
Under Examination
Approved for Publication
Dec 21, 2021
Published for Opposition
Dec 21, 2021
Registered
Mar 8, 2022

Trademark Image

EXENT

Basic Information

Serial Number
79298814
Registration Number
6661783
Filing Date
February 17, 2020
Registration Date
March 8, 2022
Published for Opposition
December 21, 2021
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Mar 8, 2022
Registration
Registered
Classes
010

Rights Holder

The Binding Site Group Limited

99
Address
8 Calthorpe Road,
Edgbaston Birmingham, West Midlands B151
GB

Ownership History

The Binding Site Group Limited

Original Applicant
99
GB

The Binding Site Group Limited

Owner at Publication
99
GB

The Binding Site Group Limited

Original Registrant
99
GB

Legal Representation

Attorney
Laura T. Geyer

USPTO Deadlines

Next Deadline
969 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-03-08)
Due Date
March 08, 2028
Grace Period Ends
September 08, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

38 events
Date Code Type Description
Apr 21, 2024 NREP P NEW REPRESENTATIVE AT IB RECEIVED
Feb 27, 2023 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 6, 2023 FICS P FINAL DISPOSITION NOTICE SENT TO IB
Feb 6, 2023 FIMP P FINAL DISPOSITION PROCESSED
Dec 27, 2022 GPNX P NOTIFICATION PROCESSED BY IB
Nov 10, 2022 LIMN I LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Nov 8, 2022 NOSU I NOTICE OF SUIT
Jul 16, 2022 LIMG M LIMITATION OF GOODS RECEIVED FROM IB
Jun 8, 2022 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 8, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER
Dec 21, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 21, 2021 PUBO A PUBLISHED FOR OPPOSITION
Dec 1, 2021 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 1, 2021 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 1, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 15, 2021 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 15, 2021 XAEC I EXAMINER'S AMENDMENT ENTERED
Nov 15, 2021 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 15, 2021 GNEA O EXAMINERS AMENDMENT E-MAILED
Nov 15, 2021 CNEA R EXAMINERS AMENDMENT -WRITTEN
Jun 21, 2021 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED
Jun 21, 2021 GNFR O FINAL REFUSAL E-MAILED
Jun 21, 2021 CNFR R FINAL REFUSAL WRITTEN
May 26, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
May 26, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
May 26, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 12, 2021 ATRV O ATTORNEY REVIEW COMPLETED
Apr 7, 2021 LIME X LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Jan 4, 2021 RFNT P REFUSAL PROCESSED BY IB
Jan 3, 2021 LIMG M LIMITATION OF GOODS RECEIVED FROM IB
Dec 11, 2020 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 11, 2020 RFRR P REFUSAL PROCESSED BY MPU
Dec 4, 2020 MAFR O APPLICATION FILING RECEIPT MAILED
Dec 2, 2020 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 1, 2020 CNRT R NON-FINAL ACTION WRITTEN
Nov 30, 2020 DOCK D ASSIGNED TO EXAMINER
Nov 30, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 26, 2020 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB

Detailed Classifications

Class 010
Medical apparatus and instruments, namely, analyzers for medical diagnostic use for measurement of analytes in bodily fluid; medical apparatus and instruments, namely, apparatus for blood analysis; medical apparatus and instruments, namely, medical apparatus used in implementing diagnostic tests designed to detect abnormalities in blood, serum urine, CSF and plasma; medical diagnostic apparatus and instruments, namely, apparatus for medical diagnostic testing in the fields of cancer, immunology, haematology; medical devices for detecting cancer and immunological disorders; medical apparatus for detecting cancer; medical diagnostic instruments for analysis of body fluids; medical diagnostic apparatus for immunological testing and for laboratory testing on blood or bodily fluids or extracts from blood or body fluids, all being in kit form; parts and fittings for all the aforesaid goods

Additional Information

Design Mark
The mark consists of the wording EXENT in black underlined by a yellow heartbeat line design.
Color Claim
The color(s) black and yellow is/are claimed as a feature of the mark.

Classification

International Classes
010

USPTO Documents

Click to view cached USPTO documents for this trademark

Only administrators can request new documents from USPTO